Results 91 to 100 of about 12,090 (254)

Facial Annular Lesions in a 28‐Year‐Old Man

open access: yes
JEADV Clinical Practice, EarlyView.
Maximiliano Maass   +3 more
wiley   +1 more source

Climate Change, Natural Disasters, and Cutaneous Fungal Infections

open access: yesInternational Journal of Dermatology, Volume 64, Issue 8, Page 1349-1355, August 2025.
ABSTRACT Fungal infections are an important source of morbidity and mortality that can manifest as superficial or invasive diseases. Diagnostic techniques for human fungal pathogens remain problematic, and multi‐drug resistance is emerging. This review addresses the potential emergence of new fungal pathogens in changing environments and reported ...
Aditya K. Gupta   +2 more
wiley   +1 more source

Dermatophytosis in companion animals: A review

open access: yesVeterinary World, 2020
Dermatophytosis, a zoonotic disease, is caused by fungi of three main genera, namely, Micropsorum, Trichophyton, and Epidermophyton. Specific lesions of dermatophyte infections are localized in the face, legs, and/or tail.
A. D. Paryuni   +2 more
semanticscholar   +1 more source

New developments in biotechnology applied to animals: An assessment of the adequacy and sufficiency of current EFSA guidance for animal risk assessment

open access: yesEFSA Journal, Volume 23, Issue 8, August 2025.
Abstract EFSA was requested by the European Commission to provide a scientific opinion on new developments in biotechnology, including new genomic techniques, as applied to animals for food, feed and other agricultural uses. A horizon‐scanning exercise identified a variety of animals obtained with new genomic techniques, with the potential to reach the
EFSA Panel on Genetically Modified Organisms (GMO)   +27 more
wiley   +1 more source

Natural infection by Microsporum canis in a capuchin monkey

open access: yesCiência Rural
: This paper described a case of a capuchin monkey (Sapajus libidinosus) with non-pruritic skin lesions. During the physical examination, multifocal areas of alopecia with crusts, erythema and scaling compatible with dermatophytosis were reported on the ...
Stéphanie Machado Mota   +5 more
doaj   +1 more source

Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial *

open access: yesBritish Journal of Dermatology, 2020
Dermatophytic infections have undergone unprecedented changes in India in the recent past. Clinical trials to find out the effectiveness of the four main oral antifungal drugs are lacking.
S. Singh   +4 more
semanticscholar   +1 more source

Fungal Spore Seasons Advanced Across the US Over Two Decades of Climate Change

open access: yesGeoHealth, Volume 9, Issue 7, July 2025.
Abstract Phenological shifts due to climate change have been extensively studied in plants and animals. Yet, the responses of fungal spores—organisms important to ecosystems and major airborne allergens—remain understudied. This knowledge gap limits our understanding of their ecological and public health implications.
Ruoyu Wu   +6 more
wiley   +1 more source

Atypical infections during combination therapy with anifrolumab and other immunosuppressives in patients with lupus erythematosus: A case series

open access: yes
JDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Shae Chambers   +8 more
wiley   +1 more source

Effectiveness and Safety of Guselkumab in Patients With Moderate‐to‐Severe Plaque Psoriasis in Real‐World Practice in Korea: A Prospective, Multicenter, Observational, Postmarketing Surveillance Study

open access: yesThe Journal of Dermatology, Volume 52, Issue 7, Page 1125-1137, July 2025.
ABSTRACT Clinical trials have demonstrated the efficacy and safety of guselkumab in patients with moderate‐to‐severe plaque psoriasis. Real‐world evidence for guselkumab in Korea is needed to establish drug safety and effectiveness under real‐world practice in this population.
Bong Seok Shin   +13 more
wiley   +1 more source

Home - About - Disclaimer - Privacy